DUFIL Snaps Up May & Baker’s Food Production Line in N775Million Deal

Must Read

TAJBank Launches Nigeria’s 2nd Non-Interest Financial Institution (Photos)

Abuja Nigeria   December 2nd 2019, TAJBank, Nigeria’s second Non –Interest financial institution, has announced the launch of its services...

Hotel Group BON to Open 22 Properties in Nigeria’s Major cities, Secondary towns

International hospitality group BON Hotels says it plans to open over 22 hotels in Nigeria’s major cities and secondary...

Amazing Ankara Styles To Wear To An Occasion

If you have been recently invited to a wedding in Nigeria, there are lots of good options. From Aso Ebi to lace...
- Advertisement -
- Advertisement -

May & Baker Nigeria PLC, a leading player in the Fast Moving Consumer Goods (FMCG) industry, and healthcare space, on Thursday 26th April 2018, sold its food production line, worth some N775 million to DE United Foods Industries Limited (DUFIL), owners of Indomie noodles.

May & Baker’s food production line covers its noodles business under the brand name, Mimee Noodles.

It was a 100 percent acquisition of May and Baker’s food division, and less than 10 percent of its total balance sheet size, according to Sandra Aduba, May and Baker’s head of Communication Department.

“The Noodles industry is a red ocean and a loss contributing unit for us hence the decision to sell. The board and shareholders approved the sale at an EGM held on 23rd Nov. 2017,” Aduba said in an emailed response to questions.

Dufil said it embarked on the acquisition “in furtherance of our aim to contribute to the growth of the Nigerian economy, enhance production capacity and focus on non-oil exports to meet the needs of  Economic Community Of West African States(ECOWAS) market and beyond which, will deliver optimum values to all our stakeholders,” the noodles giant said.

May & Baker shares have risen 3.85 percent this year, according to data compiled by BusinessDay and were priced at N2.70 as at the close of trading in Lagos on Monday, with a market capitalization of N2.6 billion.

Read:  29 Lucky Consumers Win N3m in ‘My Indomie My Remix” Video Contest (Pictures)

According to its full-year 2017 financial report, the drug maker reported an 802 percent surge in Profit After tax (PAT) from N41 million in 2016 to N370 million in 2017, signalling an end to a scathing foreign exchange liquidity problem that ravaged the sector in 2016, spurring high operational cost since most of their inputs were mainly imported.

The FMCG firm said the acquisition was completed following receipt of approvals from the respective boards of Directors of DE United and M&B, the respective shareholders of both companies and the Securities and Exchange Commission (SEC).

Read:  World food prices jump in November - FAO

The Central bank Of Nigeria (CBN)’s decision to restrict specific items from accessing its official window in 2016 placed significant pressure on input costs for FMCGs, as they had to source for Foreign exchange (FX) from the parallel market at higher rates to settle import bills which consequently depressed gross margins.

In response to this, several FMCG companies developed backward integration strategies and effective supply chain management to reduce over-reliance on imports to militate against exchange rate volatility that has hitherto hampered growth

One could have wondered why the drug making firm resolved in selling out some of its asset giving the firm’s 2017 tremendous performance and a great rebound of economic activities.

Read:  WITH CONSUMER CONFIDENCE UP LAST YEAR, 2018 SHOWS PROMISE FOR GLOBAL PRODUCT COMPANIES

Aduba disclosed that the divestment from the Noodles business provides much-needed cash for the company, and will also reduce the losses hitherto contributed by this unit by helping management refocus on its new corporate vision which is “to be a leading healthcare brand in Sub-Saharan Africa.”

“We are re-focusing on our new vision of being a leading healthcare brand not just in Nigeria but in the SSA region leveraging on our Biovaccines JV with the government”.

“Our new Agreement with National Institute for Pharmaceutical Research and Development (NIPRD) to launch a new sickle cell drug;  launching of our nature care brands and new products portfolio.”

“We are focused on delivering excellent returns for our shareholders and good value for all stakeholders. We will also be coming out to the stock market to raise fresh capital this year to drive our new vision,” Aduba added.

Dufil was incorporated in Nigeria as a private limited liability company on 16 September 1993 and has been involved in the manufacturing, selling, marketing and distributing of instant noodles ( under the indomie brand) since its inception.

 

SOURCE: BusinessDay Nigeria

- Advertisement -

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

Latest News

Anthony Joshua beats Andy Ruiz to win back world heavyweight titles

Anthony Joshua is the heavyweight champion of the world once more. Having suffered one of the biggest upsets in boxing history back...

News Highlights of November 2019 (Video)

It was a November to remember, as the battle for survival continues among brands, new ventures, opportunities, investments and the making of a payment...

Video Streaming Market to Reach $149.34 Bn Globally by 2026 at 18.3% – Report

Allied Market Research published a report, titled, "Video streaming market by Component (Solution and Services), Solution Type (IPTV, Over-the-top, and Pay TV), Streaming Type (Live/Linear...

Lagos State to commence issuance of license, permit for Boreholes Drilling in 2020

Lagos State Water Regulatory Commission is to commence issuance of licenses and permits for water abstraction in the state by the first quarter of...

May & Baker Nigeria Agrees to Manufacture 4 Product Brands for Sanofi in New Deal

The National Agency for Food & Drug Administration & Control (NAFDAC) has expressed strong support for the efforts by Sanofi, a multinational healthcare company,...

More Articles Like This